1. 2022-RA-1074-ESGO AGO-OVAR 2.29 (ENGOT-ov34): atezolizumab in combination with bevacizumab and chemotherapy vs bevacizumab and chemotherapy in recurrent ovarian cancer. (20th October 2022) Authors: Harter, Philipp; Marmé, Frederik; Pietzner, Klaus; Reuss, Alexander; Ray-Coquard, Isabelle; Redondo, Andrés; Oaknin, Ana; Jonuskiene, Goda; Lindemann, Kristina; Kurzeder, Christian; Huober, Jens; van Nieuwenhuysen, Els; Henry, Stephanie; Marth, Christian; Tsibulak, Irina; Cron, Nadin; Pautier, Pa... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial. (20th October 2022) Authors: Fotopoulou, Christina; Sehouli, Jalid; Vergote, Ignace; Reuss, Alexander; Leheurteur, Marianne; Hilpert, Felix; Savoye, Aude-Marie; Greggi, Stefano; Vernersson, Johanna; Resch, Benoît; Gatineau, Michel; Levêque, Jean; Zang, Rongyu; Jensen, Pernille T; Kim, Jae W; Santiago, Domingo; Raspagliesi, F... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-798-ESGO Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II). (20th October 2022) Authors: Harter, Philipp; Ataseven, Beyhan; Burges, Alexander; Reuss, Alexander; Kommoss, Stefan; Sehouli, Jalid; Lampe, Björn; Schmalfeldt, Barbara; Wimberger, Pauline; Witteler, Ralf; Buderath, Paul; Herwig, Uwe; Bronger, Holger; Emons, Günter; Klar, Maximilian; Hasenburg, Annette; de Gregorio, Nikolaus... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-800-ESGO AGO-OVAR 27: window-of-opportunity proof-of-concept, non-randomized, open-label phase ii trial of olaparib given alone or in combination with durvalumab prior to primary debulking surgery in histologically proven high-grade epithelial ovarian cancer. (20th October 2022) Authors: Marmé, Frederik; Heitz, Florian; Harter, Philipp; Reuss, Alexander; Kipkeew, Friederike; Wimberger, Pauline; Bronger, Holger; Bois, Andreas du; Sehouli, Jalid; Hilpert, Felix Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-909-ESGO AGO-OVAR 28/ENGOT-ov57: niraparib vs niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer (a multicentre randomised phase III trial). (20th October 2022) Authors: Heitz, Florian; Marth, Christian; Henry, Stéphanie; Reuss, Alexander; Cibula, David; Gaba, Lydia; Colombo, Nicoletta; Polleis, Sandra; Harter, Philipp Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Issue 1 (1st January 2016) Authors: Sagae, Satoru; Monk, Bradley J.; Pujade-Lauraine, Eric; Gaffney, David K.; Narayan, Kailash; Ryu, Sang Young; McCormack, Mary; Plante, Marie; Casado, Antonio; Reuss, Alexander; Chávez-Blanco, Adriana; Kitchener, Henry; Nam, Byung-Ho; Jhingran, Anuja; Temkin, Sarah; Mileshkin, Linda; Berns, Els; S... Journal: International journal of gynecological cancer Issue: Volume 26:Issue 1(2016) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Issue 1 (January 2016) Authors: Sagae, Satoru; Monk, Bradley J.; Pujade-Lauraine, Eric; Gaffney, David K.; Narayan, Kailash; Ryu, Sang Young; McCormack, Mary; Plante, Marie; Casado, Antonio; Reuss, Alexander; Chávez-Blanco, Adriana; Kitchener, Henry; Nam, Byung-Ho; Jhingran, Anuja; Temkin, Sarah; Mileshkin, Linda; Berns, Els; S... Journal: International journal of gynecological cancer Issue: Volume 26:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: A metaanalysis of four prospective randomised phase III trials with 5114 patients. Issue 7 (May 2015) Authors: Sehouli, Jalid; Fotopoulou, Christina; Erol, Edibe; Richter, Rolf; Reuss, Alexander; Mahner, Sven; Lauraine, Eric Pujade; Kristensen, Gunnar; Herrstedt, Jörn; du Bois, Andreas; Pfisterer, Jacobus Journal: European journal of cancer Issue: Volume 51:Issue 7(2015:May) Page Start: 825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34). Issue 12 (30th June 2020) Authors: Harter, Philipp; Pautier, Patricia; Van Nieuwenhuysen, Els; Reuss, Alexander; Redondo, Andres; Lindemann, Kristina; Kurzeder, Christian; Petru, Edgar; Heitz, Florian; Sehouli, Jalid; Degregorio, Nikolaus; Wimberger, Pauline; Burges, Alexander; Cron, Nadin; Ledermann, Jonathan; Lorusso, Domenica; ... Journal: International journal of gynecological cancer Issue: Volume 30:Issue 12(2020) Page Start: 1997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al. Issue 2 (1st February 2017) Authors: Harter, Philipp; Reuss, Alexander; Sehouli, Jalid; Chiva, Luis; du Bois, Andreas Journal: International journal of gynecological cancer Issue: Volume 27:Issue 2(2017) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗